Live
- MLA Mekapati Vikram Reddy says people eagerly waiting for Jagananna's Manifesto"
- MLA Candidate Satya Kumar Yadav Welcomes 50 Families to BJP, Credits Party for Global Recognition of India"
- NDA Alliance Candidate Badeti Radhakrishnaiah (Chanti) Campaigns in Eluru Constituency with Bicycle Symbol"
- TDP Is the only party that stands by farmers, says NDA alliance candidate Julakanti
- "Mana Kosam Mana Nayakkar Program Organized in Narasapuram Constituency by Janasena, TDP and BJP Parties"
- Keshineni Shivnath Leads Major Additions to TDP as City Celebrities Join in Support
- Srikakulam: TDP dissident leader Venkata Ramana relents
- KTR to hoist party flag on Formation Day today
- KCR, KTR, Harish hit campaign trail
- Visakhapatnam: VV Lakshminarayana seeks police protection
Glenmark gets nod for blood pressure drugs
Highlights
Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (US FDA) for Bisoprolol Fumarate and Hydrochlorothiazide which are used to treat blood pressure.
Hyderabad: Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (US FDA) for Bisoprolol Fumarate and Hydrochlorothiazide which are used to treat blood pressure.
The tablets are of strength 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg. These are generic versions of Ziac tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, of Teva Branded Pharmaceutical Products R&D. According to IQVIATM sales data for the 12 month period ending November 2021, these drugs achieved annual sales of approximately $30.3 million.
Glenmark's current portfolio consists of 172 products authorized for distribution in the US marketplace and 46 ANDA's pending approval with the US FDA.
Next Story
ADVERTISEMENT
